RBC Capital Initiates Coverage of Cencora (COR) with Sector Perform Recommendation
Fintel15 days agoCOR
$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.61% on an annualized basis producing an average annual return of 19.99%. Currently, Cencora has a market capitalization of $60.51 billion.
Benzinga16 days agoCOR
RBC Capital Initiates Coverage On Cencora with Sector Perform Rating, Announces Price Target of $330
RBC Capital analyst Ryan Halsted initiates coverage on Cencora (NYSE:COR) with a Sector Perform rating and announces Price Target of $330.
Benzinga16 days agoCOR
Cencora (COR): Leveraging Healthcare Growth and AI-Driven Productivity
Alpha Wealth Funds, LLC, an investment management company, released its Q2 2026 letter for the “Insiders Fund”. A copy of the letter is available to download here. The Fund lost 1.45% in June, while it was up 8.43% for the 2nd quarter and 0.75% YTD. This compares to the S&P 500’s -0.95%, 15.2%, and 9.98% […]
Yahoo21 days agoCOR
5 Insightful Analyst Questions From Cencora’s Q2 Earnings Call
Cencora’s second quarter was marked by performance that met Wall Street’s expectations on revenue and exceeded consensus on non-GAAP profitability, driving a positive market response. Management credited execution in specialty pharmaceuticals, especially through its Management Services Organizations (MSOs) like OneOncology and RCA, as a core driver of growth, while digital transformation initiatives improved operational efficiency. CEO Robert Mauch highlighted the company’s unique positioning in
Yahoo21 days agoCOR
If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.29% on an annualized basis producing an average annual return of 19.83%. Currently, Cencora has a market capitalization of $59.16 billion.
Benzinga22 days agoCOR